Straumann, CH0012280076

The Straumann BLX Implant System from Straumann Holding AG - immediate placement with higher primary stability

22.06.2026 - 13:59:58 | ad-hoc-news.de

The Straumann BLX Implant System targets immediate implantation with a tapered design and a hydrophilic SLActive surface for faster osseointegration. This system keeps the Straumann Holding AG share price in focus for dental industry investors (ISIN CH0012280076).

Straumann, CH0012280076
Straumann, CH0012280076

Reviewed: ad hoc news Bestseller & Flagship desk. Edited and checked on 2026-06-22, 13:56. Details in the imprint.

the Straumann BLX Implant System sits cool and matte on a stainless steel tray, its sharply cut threads catching the light like a precision tool rather than medical hardware. In a busy surgery, a clinician feels how firmly the BLX implant bites into bone with minimal wobble. That tactile snap is exactly what Straumann is selling here.

What Straumann BLX aims to solve

The Straumann BLX Implant System is built for immediate placement and immediate restoration, especially in cases with limited bone volume. Straumann combines a highly tapered implant body with a progressive thread design to increase primary stability in soft bone zones. An official Straumann brochure describes BLX as designed for flexible treatment protocols including early loading in challenging indications.

A key feature is the SLActive surface, Straumann's chemically active and hydrophilic implant surface that promotes faster osseointegration compared with the older SLA surface. According to Straumann's clinical documentation, SLActive is intended to reduce healing time from eight weeks down to as little as three to four weeks in suitable cases. The SLActive document highlights increased bone-to-implant contact and earlier stability peaks.

Design details in daily practice

Implantologist Dr. Markus Schlee, who appears in Straumann case reports, points to the aggressive apical cutting flutes of BLX that help it self-tap even in softer posterior maxilla bone. In the handpiece, the implant feels more like a well-balanced screw than a cylindrical plug, letting the surgeon fine-tune angulation as insertion torque rises. That controlled resistance is critical when aiming for 35 Ncm or more to support immediate crowns.

BLX uses an internal conical connection with a six-sided index, compatible with the Bone Level prosthetic portfolio. This allows dentists to use the same prosthetic components across BLX and more traditional Bone Level implants, simplifying inventory in the practice. Compatible prosthetics include titanium bases, angulated solutions and screw-retained abutments, giving restorative dentists a wide playground for full-arch cases.

Go deeper

Background on Straumann Holding AG shares

Implant systems like BLX sit at the core of Straumann's premium portfolio and help explain why the group remains a reference name in dental implants and biomaterials worldwide.

Indications, workflows and limits

Straumann positions BLX as suitable for a broad range of indications from single-tooth gaps to full-arch rehabilitations in edentulous jaws. The system is optimized for digital workflows, with guided surgery sleeves and CAD/CAM prosthetic options that integrate into coDiagnostiX planning software. Product information sheets show drilling protocols for bone classes D1 to D4.

However, BLX is not a magic bullet. In very thin ridges or extremely compromised sites, clinicians still need bone augmentation or staged approaches. The more aggressive thread can generate higher insertion torque, which demands careful control to avoid over-compression and potential necrosis, especially in dense anterior mandible bone.

Pricing and market position

BLX sits firmly in the premium price segment, above many value-tier implant brands from competitors. In Europe, individual BLX implants typically retail to practices at several hundred euros per piece, depending on contract terms and volume. Straumann justifies the pricing with surface technology, precision manufacturing and long-term clinical backing, which many implantologists accept as part of a risk-averse treatment philosophy.

For Straumann, BLX expands the existing Bone Level Tapered line into the immediate-placement niche where competitors like Nobel Biocare and Dentsply Sirona have strong offerings. By tying BLX into its digital ecosystem of guided surgery tools, intraoral scanners and prosthetic components, Straumann tries to secure more of each case's value chain rather than selling a single screw per patient.

Company context and shares

Straumann Holding AG, headquartered in Basel, has built its name on premium implants, biomaterials and digital dentistry software. BLX is one of the pillars in Straumann's effort to capture more immediate-loading and full-arch cases globally. Straumann shares (ISIN CH0012280076) trade primarily on SIX Swiss Exchange in Swiss francs and reflect investor expectations on how fast advanced systems like BLX gain share in clinics.

Key facts on the Straumann BLX Implant System

  • Product: Straumann BLX Implant System
  • Manufacturer: Straumann Holding AG
  • Category: Flagship/Bestseller dental implant system
  • Launch: Initially introduced around 2019 in key markets
  • RRP / Price: Premium segment, typically several hundred euros per implant in Europe (practice purchase price)
  • Availability: Sold via Straumann distributors and direct sales to dental clinics and implantologists worldwide
  • Target group: Dental surgeons and implantologists focusing on immediate placement and early loading
  • Highlight / USP: Tapered design with SLActive surface for high primary stability and faster osseointegration in immediate protocols

Find clinical impressions and cases

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | CH0012280076 | STRAUMANN | boerse | 69602714 | bgmi